期刊文献+

肝病患者血清肉碱水平的临床研究 被引量:3

Significance of serum carnitine in patients with liver diseases
原文传递
导出
摘要 目的观察肝病患者血清肉碱水平,探讨其临床意义,为肉碱治疗肝病提供依据。方法用酶循环法检测25例急性病毒性肝炎,34例慢性病毒性肝炎,22例肾功能正常及9例肾功能异常的肝炎后肝硬化患者血清游离肉碱水平,并分别与40名正常人的检测值比较。结果血清游离肉碱:正常人为(48.3±10.2)μmol/L;急性病毒性肝炎患者为(35.2±13.2)μmol/L,明显低于正常对照组,P=0.000。慢性病毒性肝炎患者为(36.5±9.9) μmol/L,明显低于正常对照组,P=0.000。肾功能正常的肝炎后肝硬化患者为(45.0±11.0)μmol/L,比正常对照组略有下降,但差异无统计学意义,P=0.232。肾功能异常的肝炎后肝硬化患者为(83.6±50.4)μmol/L,比正常对照组升高,但差异无统计学意义,P=0.069。结论肝病患者可发生肉碱代谢异常,肝脏疾病是导致继发性肉碱缺乏的原因之一。 Objective To determine serum carnitine levels in patients with liver diseases and to investigate their significance. Methods 25 patients with acute viral hepatitis, 34 with chronic viral hepatitis, 22 with post hepatitis cirrhosis with normal renal function, 9 with post hepatitis cirrhosis but with renal disfunction, and 40 healthy subjects (serving as controls) were enrolled in this study. An enzymatic cycling method was used.to determine the serum free carnitine levels. Results The serum free camitine level was (48.3 ± 10.2) μmol/L in the healthy control group. It was (35.2 ± 13.2) μmol/L in the acute viral hepa- titis group, (36.5 ± 9.9) μmol/L in the chronic viral hepatitis group, (45.0 ± 11.0) vmol/L in the post hepatitis cirrhosis with normal renal function group, and (83.6 ± 50.4)μmol/L in the post hepatitis cirrhosis with renal dysfunction group. Serum free carnitine levels in the acute viral hepatitis and chronic viral hepatitis groups were significantly lower than those in the healthy controls. There were no significant differences in serum free carnitine levels of the post hepatitis cirrhosis group and the normal control group. Condusions Patients with liver diseases can have carnitine metabolism errors. One of the secondary carnitine lack causes is liver disease.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2006年第5期367-369,共3页 Chinese Journal of Hepatology
关键词 肝疾病 肉碱 研究 Liver diseases Carnitine Research
  • 相关文献

参考文献5

二级参考文献8

共引文献14109

同被引文献31

  • 1房玥晖,蔡美琴.肉碱缺乏及其相关疾病的研究进展[J].中华临床营养杂志,2009,17(5). 被引量:3
  • 2韩连书,高晓岚,叶军,邱文娟,顾学范.串联质谱技术在有机酸血症筛查中的应用研究[J].中华儿科杂志,2005,43(5):325-330. 被引量:64
  • 3李文辉.血脂正常的脂肪肝病人的临床特征(附137例分析)[J].临床和实验医学杂志,2006,5(11):1734-1735. 被引量:2
  • 4萧树东.胃肠病学和肝病学[M].上海:世界图书出版公司,2004:648-649.
  • 5Mc Cullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease [ J ], Clin Liver Dis, 2004, 8:521 - 533.
  • 6Reda E, lddio SD, Nicola R, et al. The carnitine system and body composition [ JJ. Acta Diabeto,2003,40( suppi 1 ) : S106 S11.
  • 7刘苏,曾欣,沈健伟,陈岳祥,谢渭芬.左旋卡尼汀治疗非酒精性脂肪性肝病的临床评价[J].胃肠病学和肝病学杂志,2007,16(5):414-416. 被引量:2
  • 8Marcello Romano,Marco Vacante,Erika Cristaldi,Valentina Colonna,Maria Pia Gargante,Lisa Cammalleri,Mariano Malaguarnera.l-Carnitine Treatment Reduces Steatosis in Patients with Chronic Hepatitis C Treated with α-Interferon and Ribavirin[J]. Digestive Diseases and Sciences . 2008 (4)
  • 9Selimoglu MA,Yagci RV.Plasma and liver carnitine levels of children with chronic hepatitis B. Journal of Clinical Gastroenterology . 2004
  • 10L apinski TW,Grzeszczuk A.The impact of carnitine on serum ammonia concentration and lipid metabolism in patients with alcoholic liver cirrhosis. Polski Merkuriusz Lekarski . 2003

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部